ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

ClinicalTrials.gov ID: NCT05218655

Public ClinicalTrials.gov record NCT05218655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial Disease

Study identification

NCT ID
NCT05218655
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
PTC Therapeutics
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

  • Vatiquinone Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2022
Primary completion
Apr 14, 2025
Completion
Apr 14, 2025
Last update posted
Dec 21, 2025

2022 – 2025

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
University of California, San Diego Altman Clinical and Translational Research Institute La Jolla California 92037
Stanford University Stanford California 94305
Yale Medicine New Haven Connecticut 06511
Children's National Washington D.C. District of Columbia 20010
Child Neurology Center of Northwest Florida Gulf Breeze Florida 32561
The Johns Hopkins University Baltimore Maryland 21205
Columbia University Medical Center - CUMC New York New York 10032
Akron Children's Hospital Akron Ohio 44308
Cleveland Clinic Cleveland Ohio 44195
Children's Hospital of Philadelphia - CHOP Philadelphia Pennsylvania 19104
Medical University of South Carolina - MUSC Charleston South Carolina 29425
Baylor College of Medicine Houston Texas 77030
UT Health The University of Texas Houston Texas 77030
Seattle Children Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05218655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05218655 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →